The obesity paradox in community-acquired bacterial pneumonia

被引:77
|
作者
Corrales-Medina, Vicente F. [1 ]
Valayam, Josemon [2 ]
Serpa, Jose A. [2 ]
Rueda, Adriana M. [3 ]
Musher, Daniel M. [2 ,3 ,4 ]
机构
[1] Univ Ottawa, Dept Med, Div Infect Dis, Ottawa Hosp, Ottawa, ON K1Y 4E9, Canada
[2] Baylor Coll Med, Dept Med, Houston, TX 77030 USA
[3] Michael E DeBakey Vet Affairs Med Ctr Houston, Infect Dis Sect, Houston, TX USA
[4] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA
关键词
Pneumonia; Body mass index; Obesity; Mortality; Outcomes; PROGNOSIS; MORTALITY; DISEASE;
D O I
10.1016/j.ijid.2010.09.011
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: The impact of obesity on the outcome of pneumonia is uncertain. Methods: We retrospectively identified 266 hospitalized patients with proven pneumococcal or Haemophilus community-acquired pneumonia who had at least one body mass index (BMI, kg/m(2)) value documented in the 3 months before admission. Patients were classified as underweight (BMI < 18.5), normal weight (BMI 18.5 to <25), overweight (BMI 25 to <30), or obese (BMI >= 30). The association of absolute BMI values and BMI categories with the mortality at 30 days after admission for pneumonia was investigated. Results: Increasing BMI values were associated with reduced 30-day mortality, even after adjustment for significant covariates (odds ratio 0.88, confidence interval 0.81-0.96; p < 0.01). There was a significant trend towards lower mortality in the overweight and obese (non-parametric trend, p = 0.02). Conclusions: Our data suggest that obesity may exert a protective effect against 30-day mortality from community-acquired bacterial pneumonia. (C) 2010 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:E54 / E57
页数:4
相关论文
共 50 条
  • [31] COMMUNITY-ACQUIRED BACTERIAL PNEUMONIA REQUIRING ADMISSION TO HOSPITAL
    KLIMEK, JJ
    AJEMIAN, E
    FONTECCHIO, S
    GRACEWSKI, J
    KLEMAS, B
    JIMENEZ, L
    AMERICAN JOURNAL OF INFECTION CONTROL, 1983, 11 (03) : 79 - 82
  • [32] Viral and bacterial aetiology of community-acquired pneumonia in adults
    Huijskens, Elisabeth G. W.
    van Erkel, Adriana J. M.
    Palmen, Fernand M. H.
    Buiting, Anton G. M.
    Kluytmans, Jan A. J. W.
    Rossen, John W. A.
    INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2013, 7 (04) : 567 - 573
  • [33] Approach to Common Bacterial Infections: Community-Acquired Pneumonia
    Tam, Pui-Ying Iroh
    PEDIATRIC CLINICS OF NORTH AMERICA, 2013, 60 (02) : 437 - +
  • [34] Lefamulin vs moxifloxacin for community-acquired bacterial pneumonia
    Tang, Hung-Jen
    Wang, Jui-Hsiang
    Lai, Chih-Cheng
    MEDICINE, 2020, 99 (29) : E21223
  • [35] Community-acquired pneumonia
    Roaf, E
    LANCET, 1998, 352 (9145): : 2019 - 2019
  • [36] Community-Acquired Pneumonia
    Wunderink, Richard G.
    Waterer, Grant W.
    NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (06): : 543 - 551
  • [37] Community-acquired pneumonia
    Brown, Jeremy S.
    CLINICAL MEDICINE, 2012, 12 (06) : 538 - 543
  • [38] Community-acquired pneumonia
    Kolditz, M.
    Hoeffken, G.
    PNEUMOLOGE, 2009, 6 (03): : 179 - 190
  • [39] Community-acquired pneumonia
    Jose, Ricardo J.
    Periselneris, Jimstan N.
    Brown, Jeremy S.
    CURRENT OPINION IN PULMONARY MEDICINE, 2015, 21 (03) : 212 - 218
  • [40] COMMUNITY-ACQUIRED PNEUMONIA
    WHITE, R
    PRACTITIONER, 1986, 230 (1413) : 223 - 226